Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen Jones

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 29, 2024
The impact of the COVID-19 public health response on service demand and patient perceptions in a tertiary Australian gynaecology oncology unitNooraishah Yasin, Michael Yu, Kristen Jones, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 1, 2025
Before the Burn: Predicting Endometrial Ablation FailureAnne Woolfield, Jessica Phillips, Ian Hughes, et al.
Molecular Cancer Therapeutics|December 15, 2021
Resistance Profile and Structural Modeling of Next-Generation ROS1 Tyrosine Kinase InhibitorsClare Keddy, Pushkar Shinde, Kristen Jones, et al.
Nanotechnology|September 16, 2011
Role of dopant concentration, crystal phase and particle size on microbial inactivation of Cu-doped TiO2 nanoparticlesManoranjan Sahu, Bing Wu, Liying Zhu, et al.
Chemmedchem|August 20, 2019
Second-Generation Inhibitors of the Mitochondrial Permeability Transition Pore with Improved Plasma StabilityJustina Šileikytė, Jordan Devereaux, Jelle de Jong, et al.
Neurosurgery|February 14, 2025
The Role of Minimally Invasive Surgery in Spinal Trauma: A Review of Techniques, Outcomes, and LimitationsMounica R Paturu, Joshua Woo, Brett Rocos, et al.
NPJ Precision Oncology|August 8, 2024
TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
TKI Type Switching Overcomes ROS1 L2086F in ROS1 Fusion-Positive CancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
NPJ Precision Oncology|August 28, 2024
Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
EMBO Molecular Medicine|August 17, 2023
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitorsSudarshan R Iyer, Kevin Nusser, Kristen Jones, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 29, 2024
The impact of the COVID-19 public health response on service demand and patient perceptions in a tertiary Australian gynaecology oncology unitNooraishah Yasin, Michael Yu, Kristen Jones, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 1, 2025
Before the Burn: Predicting Endometrial Ablation FailureAnne Woolfield, Jessica Phillips, Ian Hughes, et al.
Molecular Cancer Therapeutics|December 15, 2021
Resistance Profile and Structural Modeling of Next-Generation ROS1 Tyrosine Kinase InhibitorsClare Keddy, Pushkar Shinde, Kristen Jones, et al.
Nanotechnology|September 16, 2011
Role of dopant concentration, crystal phase and particle size on microbial inactivation of Cu-doped TiO2 nanoparticlesManoranjan Sahu, Bing Wu, Liying Zhu, et al.
Chemmedchem|August 20, 2019
Second-Generation Inhibitors of the Mitochondrial Permeability Transition Pore with Improved Plasma StabilityJustina Šileikytė, Jordan Devereaux, Jelle de Jong, et al.
Neurosurgery|February 14, 2025
The Role of Minimally Invasive Surgery in Spinal Trauma: A Review of Techniques, Outcomes, and LimitationsMounica R Paturu, Joshua Woo, Brett Rocos, et al.
NPJ Precision Oncology|August 8, 2024
TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
TKI Type Switching Overcomes ROS1 L2086F in ROS1 Fusion-Positive CancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
NPJ Precision Oncology|August 28, 2024
Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancersRajat Thawani, Matteo Repetto, Clare Keddy, et al.
EMBO Molecular Medicine|August 17, 2023
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitorsSudarshan R Iyer, Kevin Nusser, Kristen Jones, et al.
Pageof 5